More articles from Letters to the editor

  • Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    Rene Rodríguez-Gutiérrez, MD and José Gerardo González-González, MD, PhD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 236; DOI: https://doi.org/10.3949/ccjm.79c.04001

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Parkinson disease (January 2012)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242-243; DOI: https://doi.org/10.3949/ccjm.79c:04006

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Essential tremor, beta-blockers, and calcium channel blockers (December 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242; DOI: https://doi.org/10.3949/ccjm.79c:04004

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • In Reply: Parkinson disease (January 2012)
    Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 243-248; DOI: https://doi.org/10.3949/ccjm.79c:04007

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • In Reply: Essential tremor, beta-blockers, and calcium channel blockers (December 2011)
    Hesham Abboud, MD, Anwar Ahmed, MD and Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242; DOI: https://doi.org/10.3949/ccjm.79c:04005

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 236-237; DOI: https://doi.org/10.3949/ccjm.79c.04002

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • In Reply: Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    M. Cecilia Lansang, MD, MPH and Leighanne Kramer Hustak, DNP, BC-FNP, CDE
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 237-242; DOI: https://doi.org/10.3949/ccjm.79c.04003

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Dabigatran (October 2011)
    Ronald Hirsch, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 166-168; DOI: https://doi.org/10.3949/ccjm.79c:03004
  • Cervical cancer screening (November 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 164; DOI: https://doi.org/10.3949/ccjm.79c:03001

    Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).

  • In reply: Dabigatran (October 2011)
    Siddharth A. Wartak, MD and John R. Bartholomew, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 168-169; DOI: https://doi.org/10.3949/ccjm.79c:03005

Pages